Table 16.
Clinical outcomes among those who received macrolides
| On admission | Total (n = 13,884) | No. (%) | 1 week after admission | Total (n = 13,884) | No. (%) | p value |
|---|---|---|---|---|---|---|
| Oxygen saturation % | Oxygen saturation % | |||||
| < 90% | 13,454 | 3,020 (22.5) | < 90% | 11,439 | 914 (12.9) | < 0.001 |
| Median (IQR) SatO2% | 94 (91–96) | Median (IQR) SatO2% | 95 (93–97) | < 0.001 | ||
| pH in arterial blood | 4721 | 7.45 (7.41–7.48) | pH in arterial blood | 1997 | 7.43 (7.38–7.46) | < 0.001 |
| pCO2 | 4785 | 34 (31–38) | pCO2 | 2017 | 40 (35–45) | < 0.001 |
| pO2 | 4578 | 66 (56–77) | pO2 | 1957 | 74 (61–91) | < 0.001 |
| pO2/FiO2 mmHg | 4380 | 290 (235–343) | pO2/FiO2 mmHg | 1844 | 223 (124–333) | < 0.001 |